Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
Functional polymorphisms in LncRNA HOTAIR contribute to susceptibility of pancreatic cancer
Minor alleles of rs4759314 and rs200349340 significantly associated with PC susceptibility.
»
02/28/19
A high throughput screening system of coils for ELF magnetic fields experiments: proof of concept on the proliferation of cancer cell lines
Proof of concept of system that sensibly reduces time and costs of screening.
»
02/28/19
Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis.
Therapeutic potential of pharmacologically inhibiting fascin.
»
11/29/18
Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer.
Combined Estrogen-Progesterone did significantly impact overall survival.
»
05/15/18
Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.
Limitations include retrospective design and relatively small sample size.
»
11/20/18
High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.
Plasma MLANA levels and tumor resectability independent prognostic factors for progression free survival.
»
10/08/17
Inhibition of apoptosis by miR‑122‑5p in α‑fetoprotein‑producing gastric cancer.
miR‑122‑5p inhibited apoptosis and facilitated tumor progression by targeting FOXO3.
»
11/14/18
Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk.
Average genotypically-estimated LTL significantly longer for those with meningioma.
»
11/12/18
Plasma HER2 (
ERBB2
) copy number predicts response to HER2-targeted therapy in metastatic colorectal cancer.
cfDNA viable alternative to tissue-based genotyping in metastatic setting.
»
02/04/19
Association of body mass index with bladder cancer risk in men depends on abdominal obesity.
Increasing BMI and increasing WC risk factors for developing bladder cancer in men.
»
11/22/18
< Prev
Next >